Archives

by in
Entry Author Date Location
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Rhythm Pharmaceuticals Secures $25,000,000 Series B Financing Round 06/04/12 Boston
Nurix Garners $3,100,000 New Funding Round 05/17/12 San Francisco
Targeted Cancer Drugs With Punch: The Next Big Class of Antibodies 05/16/12 National
Boston Life Sciences News From Vertex, Eleven, RXi, & More 05/11/12 Boston
SessionM, PlumChoice, Mojo Motors, and More Boston Dealmakers 05/09/12 Boston
Eleven Biotherapeutics Raises $20M to Advance Dry-Eye Drug 05/08/12 Boston
Eleven Biotherapeutics Secures $20,000,000 Series A Round 05/08/12 Boston
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
CoolChip, Copiun, Wingu Among the Slew of Boston Deals This Week 04/18/12 Boston
Alcresta Lands $10,000,000 Series A Round 04/18/12 Boston
Enzyme Maker Alcresta Nabs $10M from Third Rock, Bessemer, Frazier 04/17/12 Boston
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1 04/16/12 National
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
Xconomy Boston’s Top 20 Stories of Q1: Editor’s Picks 04/02/12 Boston
Third Rock’s Mark Levin: ‘Ultra-Super Positive’ on Biotech Innovation 03/29/12 Boston
Theraclone’s Cliff Stocks Joins “Reinventing Biotech” Lineup Apr. 3 03/27/12 Seattle
Aveo’s Ha-Ngoc to Interview Third Rock’s Mark Levin at April 4 Forum 03/26/12 Boston
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Kala Pharmaceuticals Lands $6,200,000 Seed Round 03/14/12 Boston
New England’s Emerging Biotech Stars: The Agenda 03/08/12 Boston
CytomX Therapeutics Seeks to One-Up Lilly, Amgen Cancer Drugs 03/02/12 San Francisco
Reinventing Biotech: Meet Corey Goodman, Kevin Starr & More April 3 02/23/12 Seattle
Option to Buy: The New Face of Biotech Funding? 02/13/12 National
New England’s Rising Biotech CEOs to Gather at April 4 Xconomy Event 01/26/12 Boston
Biotech Is Raising More Cash, But Don’t Be Fooled: Startups are Hurting 01/23/12 National
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3 01/19/12 Seattle
Genentech Pours $95M Into Constellation’s Drug Platform 01/17/12 Boston
Page 3 of 9 « previous page · next page »